Assura (LON:AGR) Stock Crosses Above 200-Day Moving Average – Should You Sell?

Assura Plc (LON:AGRGet Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 48.37 and traded as high as GBX 48.50. Assura shares last traded at GBX 47.48, with a volume of 288,991 shares traded.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Shore Capital reissued a “hold” rating on shares of Assura in a research report on Wednesday, October 1st. Peel Hunt reiterated a “buy” rating and issued a GBX 60 price target on shares of Assura in a report on Tuesday, September 30th. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 60.

Get Our Latest Report on AGR

Assura Price Performance

The firm’s 50 day moving average price is GBX 47.48 and its two-hundred day moving average price is GBX 48.37. The firm has a market capitalization of £1.54 billion, a PE ratio of 895.85, a P/E/G ratio of 3.60 and a beta of 0.37. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.05.

Assura Company Profile

(Get Free Report)

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.

Featured Stories

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.